Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Speedy trial platform aims to find best COVID-19 drugs

NCT ID NCT04746183

First seen Nov 01, 2025 · Last updated May 18, 2026 · Updated 25 times

Summary

This trial uses a flexible 'platform' design to rapidly test several potential treatments for COVID-19 in adults. It aims to find safe and effective doses that can reduce severe illness, hospitalization, and death. The study involves 600 participants and is currently recruiting.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COVID19 are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Desmond Tutu Health Foundation

    COMPLETED

    Cape Town, South Africa

  • Ezintsha

    COMPLETED

    Johannesburg, South Africa

  • Kings College Hospital NHS Foundation Trust

    ACTIVE_NOT_RECRUITING

    London, United Kingdom

  • Liverpool University Hospitals NHS Foundation Trust

    RECRUITING

    Liverpool, L7 8XP, United Kingdom

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-••••

    Contact

    Contact

    Contact

  • Manchester University NHS Foundation Trust

    RECRUITING

    Manchester, United Kingdom

    Contact

  • Royal Free Hospital

    RECRUITING

    London, United Kingdom

    Contact

  • University Hospital Southampton NHS Foundation Trust

    RECRUITING

    Southampton, SO16 6YD, United Kingdom

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

Conditions

Explore the condition pages connected to this study.